MRNA vs BIIB: Which Stock is Better?
Side-by-side comparison of Moderna Inc and Biogen Inc in 2026
MRNA
Moderna Inc
$53.57
BIIB
Biogen Inc
$191.82
Key Metrics Comparison
| Metric | MRNA | BIIB | Winner |
|---|---|---|---|
| Market Cap | $20.93B | $28.15B | BIIB |
| P/E Ratio | N/A | 21.82 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | -0.3% | -0.1% | BIIB |
| Gross Margin | -105.8% | 78.9% | BIIB |
Analyze MRNA
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MRNA or BIIB a better investment?
Comparing MRNA and BIIB: Moderna Inc has a market cap of $20.93B while Biogen Inc has $28.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MRNA and BIIB?
MRNA (Moderna Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MRNA or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MRNA or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.3% for MRNA.
Which company is more profitable: MRNA or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -105.8% for MRNA.
Which is the larger company: MRNA or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $28.15B compared to $20.93B for MRNA.
Should I buy MRNA or BIIB in 2026?
Both MRNA and BIIB have investment merit. MRNA trades at $53.57 while BIIB trades at $191.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MRNA and BIIB stock?
Key differences: Market Cap ($20.93B vs $28.15B), P/E Ratio (N/A vs 21.8x), Revenue Growth (-0.3% vs -0.1%), Gross Margin (-105.8% vs 78.9%).